TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Authors :: Vadakekolathu, Jayakumar
Lai, Catherine
Reeder, Stephen
Church, Sarah E.
Hood, Tressa
Lourdusamy, Anbarasu
Rettig, Michael P.
Aldoss, Ibrahim
Advani, Anjali S.
Godwin, John
Wieduwilt, Matthew J.
Arellano, Martha
Muth, John
Yau, Tung On
Ravandi, Farhad
Sweet, Kendra
Altmann, Heidi
Foulds, Gemma A.
Middeke, Jan Moritz
Ciciarello, Marilena
Curti, Antonio
Valk, Peter J. M.
Gojo, Ivana
DiPersio, John F.
Davidson-Moncada, Jan K.
Rutella, Sergio
Publication Year :: 2020
Publisher :: American Society of Hematology, 2020.

Tools